Molbio Diagnostics Limited IPO

Molbio Diagnostics Limited is listed in the MAINBOARD segment with a price band of ₹768 to ₹807. The figures below are as reported by the exchanges and public sources.

Molbio Diagnostics Limited IPO — key facts

• The Molbio Diagnostics Limited IPO price band is ₹768 to ₹807 per share.
• One lot is 18 shares, a minimum application of ₹14,526.
• As of 5 September 2026, the Molbio Diagnostics Limited IPO subscription status is 70.27x overall.
• The issue is open from 10-AUG-2026 to 12-AUG-2026.
• Molbio Diagnostics Limited listed on 17-AUG-2026.
• Molbio Diagnostics Limited listed at ₹1,036.3. The listing gain was 28.4% against the upper end of the issue price band.
• The registrar for this issue is Kfin Technologies Ltd..

Molbio Diagnostics Limited IPO details

Status

Listed

Segment

MAINBOARD

Sector

Medical Equipment & Supplies

Price band

₹768 – ₹807

Lot size

18 shares

Minimum investment

₹14,526

Issue size

₹939.7 Cr

Fresh issue

₹200.12 Cr

Offer for sale

₹739.57 Cr

Opens

10-AUG-2026

Closes

12-AUG-2026

Allotment

13-Aug-2026

Listing

17-AUG-2026

Total subscription

70.27x

Retail

12.97x

QIB

186.39x

NII

49.80x

Registrar

Kfin Technologies Ltd.

Lead managers

Kotak Mahindra Capital (left lead)

Listing price

₹1,036.3

Listing day change

+28.4%

Other Medical Equipment & Supplies IPOs

• Avience Biomedicals Limited +99.5% on listing
• QMS Medical Allied Services Limited +11.1% on listing
• Q-Line Biotech Limited +38.4% on listing
• Earkart Ltd. +5.4% on listing
• Galaxy Medicare Limited -5.0% on listing
• Laxmi Dental Limited +28.7% on listing

Live subscription, allotment status, offer documents and the full lifecycle timeline for this issue are on this page. Historical listing performance for every past IPO is in the IPO database, and each day's activity is recorded in the daily digest.

Published by INVESTOLOGY — SEBI Registered Research Analyst INH000015297. Data is reported for information only. It is not research and not investment advice. Investments in securities markets are subject to market risk; read all offer documents carefully before investing.